Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0QGJ.L Stock Summary
In the News
0QGJ.L Financial details
Company Rating
Neutral
Market Cap
56.49M
Income
-19.62M
Revenue
40.48M
Book val./share
1.23
Cash/share
1
Dividend
-
Dividend %
-
Employees
87
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-1.27
Forward P/E
-5.36
PEG
-0.13
P/S
4.17
P/B
1.25
P/C
2.25
P/FCF
-2.61
Quick Ratio
4.4
Current Ratio
4.74
Debt / Equity
0.12
LT Debt / Equity
0.08
-
-
EPS (TTM)
-0.8
EPS next Y
-0.42
EPS next Q
-
EPS this Y
-17.07%
EPS next Y
-47.5%
EPS next 5Y
-65%
EPS last 5Y
-17.69%
Revenue last 5Y
32.76%
Revenue Q/Q
-48.62%
EPS Q/Q
-69.23%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-71%
ROE
-84%
ROC
-0.3%
Gross Margin
77%
Oper. Margin
-119%
Profit Margin
-329%
Payout
-
Shs Outstand
24.56M
Shs Float
23.67M
-
-
-
-
Target Price
-
52W Range
1.385-2.77
52W High
+12.5%
52W Low
+125%
RSI
65
Rel Volume
0.08
Avg Volume
128
Volume
10
Perf Week
41.51%
Perf Month
-
Perf Quarter
-
Perf Half Y
29.31%
-
-
-
-
Beta
0.789
-
-
Volatility
0.43%, 0.29%
Prev Close
0.9%
Price
2.25
Change
-2.6%
0QGJ.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.32 | 0.43 | 0.33 | 0.43 | 1.27 | |
Net income per share | -0.9 | -0.81 | -1.18 | -0.41 | -0.34 | |
Operating cash flow per share | -0.43 | -0.67 | -1.01 | -0.44 | 0.49 | |
Free cash flow per share | -0.47 | -0.73 | -1.03 | -0.44 | 0.45 | |
Cash per share | 2.17 | 2.23 | 1.22 | 0.91 | 1.35 | |
Book value per share | 4.36 | 3.33 | 2.16 | 1.82 | 1.51 | |
Tangible book value per share | 2.83 | 1.79 | 0.88 | 0.6 | 1.11 | |
Share holders equity per share | 4.36 | 3.33 | 2.16 | 1.82 | 1.51 | |
Interest debt per share | 0.07 | 0.22 | 0.23 | 0.18 | 0.18 | |
Market cap | 187.93M | 99.22M | 87.93M | 69.76M | 54.53M | |
Enterprise value | 162.04M | 69.59M | 63.06M | 51.36M | 36.03M | |
P/E ratio | -8.85 | -4.97 | -3.05 | -6.99 | -6.55 | |
Price to sales ratio | 24.81 | 9.44 | 10.99 | 6.67 | 1.75 | |
POCF ratio | -18.53 | -6.04 | -3.55 | -6.49 | 4.55 | |
PFCF ratio | -16.85 | -5.56 | -3.48 | -6.41 | 4.97 | |
P/B Ratio | 1.82 | 1.21 | 1.65 | 1.56 | 1.47 | |
PTB ratio | 1.82 | 1.21 | 1.65 | 1.56 | 1.47 | |
EV to sales | 21.39 | 6.62 | 7.88 | 4.91 | 1.15 | |
Enterprise value over EBITDA | -7.74 | -3.89 | -3.04 | -7.25 | 2.83 | |
EV to operating cash flow | -15.98 | -4.24 | -2.54 | -4.78 | 3.01 | |
EV to free cash flow | -14.52 | -3.9 | -2.5 | -4.72 | 3.28 | |
Earnings yield | -0.11 | -0.2 | -0.33 | -0.14 | -0.15 | |
Free cash flow yield | -0.06 | -0.18 | -0.29 | -0.16 | 0.2 | |
Debt to equity | 0.01 | 0.06 | 0.1 | 0.09 | 0.1 | |
Debt to assets | 0.01 | 0.05 | 0.07 | 0.07 | 0.07 | |
Net debt to EBITDA | 1.24 | 1.65 | 1.2 | 2.6 | -1.45 | |
Current ratio | 6.52 | 5.65 | 3.23 | 3.01 | 5.02 | |
Interest coverage | -161.93 | -45.07 | -68.17 | -30.56 | -14.38 | |
Income quality | 0.48 | 0.82 | 0.86 | 1.08 | -1.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.78 | 0.63 | 0.98 | 0.59 | 0.25 | |
Research and developement to revenue | 2.26 | 1.98 | 2.32 | 0.95 | 0.23 | |
Intangibles to total assets | 0.29 | 0.35 | 0.42 | 0.51 | 0.19 | |
Capex to operating cash flow | 0.1 | 0.09 | 0.02 | 0.01 | -0.08 | |
Capex to revenue | -0.13 | -0.14 | -0.06 | -0.01 | -0.03 | |
Capex to depreciation | -0.65 | -0.6 | -0.07 | -0.04 | -0.05 | |
Stock based compensation to revenue | 0.13 | 0.05 | 0.08 | 0.06 | 0.01 | |
Graham number | 9.38 | 7.81 | 7.57 | 4.08 | 3.39 | |
ROIC | -0.22 | -0.22 | -0.44 | -0.2 | -0.19 | |
Return on tangible assets | -0.24 | -0.28 | -0.67 | -0.34 | -0.2 | |
Graham Net | 1.34 | 1.13 | 0.4 | 0.36 | 0.86 | |
Working capital | 48.7M | 47.51M | 22.56M | 16.13M | 29.84M | |
Tangible asset value | 67.02M | 43.91M | 21.52M | 14.7M | 27.28M | |
Net current asset value | 35.85M | 30.34M | 11.1M | 9.51M | 22.6M | |
Invested capital | 0.01 | 0.06 | 0.1 | 0.09 | 0.1 | |
Average receivables | 1.24M | 628K | 1.21M | 1.65M | 2.35M | |
Average payables | 1.04M | 1.37M | 903K | 465.5K | 566K | |
Average inventory | 5.17M | 1.31M | 1 | 1 | 1 | |
Days sales outstanding | 37.92 | 16.29 | 89.4 | 46.47 | 39.38 | |
Days payables outstanding | 89.71 | 185.61 | 20.36 | 37.96 | 9.71 | |
Days of inventory on hand | 173.22 | 0 | 0 | 0 | 0 | |
Receivables turnover | 9.63 | 22.41 | 4.08 | 7.86 | 9.27 | |
Payables turnover | 4.07 | 1.97 | 17.93 | 9.61 | 37.59 | |
Inventory turnover | 2.11 | 2.7M | 7.76M | 4.79M | 23.84M | |
ROE | -0.21 | -0.24 | -0.54 | -0.22 | -0.22 | |
Capex per share | -0.04 | -0.06 | -0.02 | -0.01 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.25 | 1.03 | 0.24 | 0.12 | |
Net income per share | -0.23 | -0.18 | 0.57 | -0.91 | -0.28 | |
Operating cash flow per share | -0.3 | -0.14 | 0.7 | -0.22 | -0.33 | |
Free cash flow per share | -0.3 | -0.14 | 0.7 | -0.25 | -0.35 | |
Cash per share | 0.91 | 0.91 | 1.6 | 1.35 | 1 | |
Book value per share | 2.01 | 1.82 | 2.41 | 1.51 | 1.23 | |
Tangible book value per share | 0.73 | 0.6 | 1.18 | 1.11 | 0.82 | |
Share holders equity per share | 2.01 | 1.82 | 2.41 | 1.51 | 1.23 | |
Interest debt per share | 0.2 | 0.17 | 0.16 | 0.17 | 0.14 | |
Market cap | 98.99M | 69.76M | 57.97M | 54.53M | 48.63M | |
Enterprise value | 81.38M | 51.36M | 33.32M | 36.03M | 35.57M | |
P/E ratio | -4.37 | -4.04 | 1.04 | -0.61 | -1.74 | |
Price to sales ratio | 23.07 | 11.3 | 2.29 | 9.14 | 15.87 | |
POCF ratio | -13.41 | -20.68 | 3.35 | -10.24 | -6.05 | |
PFCF ratio | -13.32 | -20.23 | 3.4 | -8.93 | -5.74 | |
P/B Ratio | 2 | 1.56 | 0.98 | 1.47 | 1.61 | |
PTB ratio | 2 | 1.56 | 0.98 | 1.47 | 1.61 | |
EV to sales | 18.97 | 8.32 | 1.32 | 6.04 | 11.61 | |
Enterprise value over EBITDA | -17.59 | -20.91 | 2.17 | -13.65 | -5.3 | |
EV to operating cash flow | -11.03 | -15.22 | 1.93 | -6.77 | -4.43 | |
EV to free cash flow | -10.95 | -14.89 | 1.95 | -5.9 | -4.19 | |
Earnings yield | -0.06 | -0.06 | 0.24 | -0.41 | -0.14 | |
Free cash flow yield | -0.08 | -0.05 | 0.29 | -0.11 | -0.17 | |
Debt to equity | 0.09 | 0.09 | 0.06 | 0.1 | 0.12 | |
Debt to assets | 0.07 | 0.07 | 0.05 | 0.07 | 0.08 | |
Net debt to EBITDA | 3.8 | 7.49 | -1.6 | 7.01 | 1.95 | |
Current ratio | 2.57 | 3.01 | 6.04 | 5.02 | 4.74 | |
Interest coverage | -32.7 | -25.24 | 102.28 | -46.02 | 0 | |
Income quality | 1.3 | 0.78 | 1.24 | 0.24 | 1.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.63 | 0.56 | 0.16 | 0.6 | 1.42 | |
Research and developement to revenue | 1.47 | 1.05 | 0.14 | 0.63 | 1.69 | |
Intangibles to total assets | 0.47 | 0.51 | 0.39 | 0.19 | 0.24 | |
Capex to operating cash flow | 0.01 | 0.02 | -0.01 | 0.15 | 0.06 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.13 | -0.15 | |
Capex to depreciation | -0.05 | -0.03 | -0.31 | -0.04 | -0.66 | |
Stock based compensation to revenue | 0.08 | 0.05 | 0.01 | 0.03 | 0.05 | |
Graham number | 3.23 | 2.69 | 5.54 | 5.54 | 2.8 | |
ROIC | -0.1 | -0.09 | 0.21 | -0.51 | -0.18 | |
Return on tangible assets | -0.16 | -0.15 | 0.3 | -0.53 | -0.22 | |
Graham Net | 0.23 | 0.36 | 0.93 | 0.86 | 0.55 | |
Working capital | 14.87M | 16.13M | 34.83M | 29.84M | 22.03M | |
Tangible asset value | 17.84M | 14.7M | 29.04M | 27.28M | 20.21M | |
Net current asset value | 6.9M | 9.51M | 24.39M | 22.6M | 15.93M | |
Invested capital | 0.09 | 0.09 | 0.06 | 0.1 | 0.12 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 20.01 | 19.42 | 3.83 | 50.88 | 39.21 | |
Days payables outstanding | 56.99 | 14.5 | 75.98 | 2.56 | 86.88 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 4.5 | 4.63 | 23.52 | 1.77 | 2.3 | |
Payables turnover | 1.58 | 6.21 | 1.18 | 35.13 | 1.04 | |
Inventory turnover | 0 | 3.09M | 815K | 22.27M | 0 | |
ROE | -0.11 | -0.1 | 0.24 | -0.6 | -0.23 | |
Capex per share | 0 | 0 | -0.01 | -0.03 | -0.02 |
0QGJ.L Frequently Asked Questions
What is Medigene AG stock symbol ?
Medigene AG is a DE stock and trading under the symbol 0QGJ.L
What is Medigene AG stock quote today ?
Medigene AG stock price is $2.25 today.
Is Medigene AG stock public?
Yes, Medigene AG is a publicly traded company.